Lincoln Pharmaceuticals Ltd Share Price

Pharmaceuticals

NSE: LINCOLN Small Cap ISIN: INE405C01035

As on 18 November 2025 at 23:55 IST

₹532.50

-0.35

(-0.07%)

Sell Buy

Over 1 Month

1.60%

Over 6 Months

-11.66%

Over 1 Year

-13.25%

Over 3 Years

77.23%

Lincoln Pharmaceuticals Ltd Summary

Close ₹532.85

Open ₹531.90

High ₹537.15

Low ₹527

Volume 27,670

Net Turnover (in Cr) ₹1.47

52Wk High ₹979.50

52Wk Low ₹490

52Wk High / Low

490

979.50

Lincoln Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹1,067.28

EPS (TTM) 39.94

Book Value (BV) 357.35

Div. Yield 0.34 %

P/E (TTM) 13.32

Price/Book Value 1.49

Delivery % 67.01 %

Face Value 10

Key Ratios

PE Ratio 13.42

PB Ratio 1.64

EV to Sales 1.74

PEG Ratio -1.14

ROA 12.15

ROE 13.02

Debt-Equity -

Net Profit Margin 13.21

Operating Profit Margin 19.89

Lincoln Pharmaceuticals Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	645.71	614.97	532.78	482.12	429.85
Total Expenses	536.52	492.73	432.30	386.18	346.13
Profit Before Tax	109.19	122.24	100.48	95.94	83.72
Profit After Tax	82.35	93.30	72.90	69.36	62.25
Operating Profit After Depreciation	111.07	123.71	102.51	97.39	85.28

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	181.97	179.33	150.53	131.88	110.64
Total Non Current Assets	297.07	253.55	220.21	181.51	143.61
Total Current Assets	499.94	446.74	367.21	352.85	308.75
Total Assets	797.01	700.29	587.42	534.36	452.36
Total Shareholder's Fund	671.67	592.84	502.47	432.88	366.39

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	93.02	63.22	39.26	76.13	69.27
Net Cash Used In Investing Activities	-78.95	-57.34	-36.64	-78.08	-64.23
Net Cash Used In Financing Activities	-6.40	-5.18	-4.50	-2.56	-5.75

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	645.71	614.97	532.79	482.08	428.65
Total Expenses	536.52	492.73	432.34	386.15	344.98
Profit Before Tax	109.19	122.24	100.46	95.93	83.67
Profit After Tax	82.35	93.30	72.90	69.35	62.25
Operating Profit After Depreciation	111.07	123.71	102.48	97.38	85.22

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	181.97	179.33	150.53	131.88	110.64
Total Non Current Assets	297.12	262.56	220.26	181.56	143.66
Total Current Assets	499.75	437.59	367	352.56	308.15
Total Assets	796.87	700.15	587.26	534.11	451.81
Total Shareholder's Fund	671.67	592.84	502.47	432.88	366.39

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	93.02	63.24	39.16	76.18	69.39
Net Cash Used In Investing Activities	-78.95	-57.34	-36.64	-78.08	-64.39
Net Cash Used In Financing Activities	-6.40	-5.18	-4.50	-2.56	-5.74

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	163.36	154.07	168.18	146.55	161.21
Total Expenses	137.93	130.26	141.46	122.89	132.84
Profit Before Tax	28.81	35.39	16.24	28.68	34.78
Profit After Tax	19.98	27.68	11.58	20.77	26.33
Operating Profit after Depreciation	32.66	39.08	19.84	32.63	38.35

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	163.36	154.07	168.18	146.55	161.21
Total Expenses	137.93	130.26	141.46	122.89	132.84
Profit Before Tax	28.81	35.39	16.24	28.68	34.78
Profit After Tax	19.98	27.68	11.58	20.77	26.33
Operating Profit after Depreciation	32.66	39.08	19.84	32.63	38.35

Lincoln Pharmaceuticals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 527.52

S2 522.18

S3 517.37

Pivot 532.33

R1 537.67

R2 542.48

R3 547.82

Moving Average

20 SMA 525.90

50 SMA 535.40

100 SMA 544.06

200 SMA 564.06

Lincoln Pharmaceuticals Ltd Corporate Actions

Lincoln Pharmaceuticals Ltd

₹1.8/Share

Announcement Date 12 Sep 2025

Record Date 12 Sep 2025

Div Yield 18%

AGM Date: 30 Sep 2021

This is to inform that the 27th Annual General Meeting ('AGM') of the members of the Company will be held on Thursday September 30 2021 at 11:00 a.m. (IST) through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM') in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India we hereby enclose the Notice of 27th Annual General Meeting of the Company which is being sent to the members through electronic mode. The same is also uploaded on the website of the Company at www.lincolnpharma.com. In compliance of various circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India the 27th AGM of the Company was held today i.e. Thursday September 30 2021 at 11: a.m. through VC / OAVM to seek the approval of members of the Company on resolutions set out in the Notice convening the Meeting. (As Per BSE Announcement Dated on 9/30/2021 2:31:01 AM) Pursuant to the provisions of Regulation 44 of SEBI (LODR) Regulations 2015 we wish to inform you that 27th Annual General Meeting of the company was held on Thursday September 30 2021 at 11:00 a.m. through Video Conferencing (VC)/Other Audio Visual Means (OAVM) in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. We enclose herewith the details of the results of voting held through remote e-voting and e-voting at the AGM along with scrutinizers report on e-voting. (As Per BSE Announcement Dated on 10/1/2021 2:39:28 AM) With reference to above please find enclosed herewith the minutes of the 27th Annual General Meeting of the Company held at 11:00 A.M. on Thursday the 30th day of September 2021 through Video Conferencing (VC) / Other Audio Visual Means (OAVM) to seek the approval of members of the Company on resolutions set out in the Notice convening the Meeting. (As Per BSE Announcement Dated on 10/20/2021 11:23:48 AM)

AGM Date: 30 Sep 2022

AGM 30/09/2022 Proceeding of the 28th Annual General Meeting of The Company-Regulation 30 of SEBI (LODR) Regulation,2015 (As Per BSE Announcement dated on 30.09.2022) Minutes of the 28th Annual General Meeting (As Per BSE Announcement Dated on 14.10.2022)

AGM Date: 30 Sep 2023

Intimation of Publication of Notice. Pursuant to the regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the 29th Annual General Meeting of the Company is scheduled to be held on Saturday, September 30, 2023 at 11:00 a.m. (IST) through video conferencing ('VC')/Other Audio-Visuals Means ('OAVM'). (As Per BSE Announcement Dated on 28/08/2023) Proceedings of the 29th Annual General Meeting of the Company held today. (As per BSE Announcement Dated on 30/09/2023) With reference to the above, please find enclosed herewith the minutes of 29th Annual General Meeting of the Company held at 11:00 A.M on Saturday, the 30th September , 2023 through Video Conferencing ('VC')/other Audio Visual Means (OVAM) to seek the approval of members of the company on resolutions set out in the Notice convening the meeting. (As Per BSE Announcement Dated on 23.10.2023)

AGM Date: 30 Sep 2024

AGM 30/09/2024 Submission of proceedings of the 30th Annual General Meeting of the Company held today. (As Per Bse Announcement Dated on 30.09.2024) Submission of Voting Results of 30th AGM along with the Scrutinizer Report as per Regulation 44 of SEBI (LODR) Regulation, 2015. Submission of Scrutinizers'' Report of 30th AGM of the Company. (As per BSE Announcement Dated on 03/10/2024) With reference to the above, please find enclosed herewith the Minutes of 30th Annual General Meeting of the Company held at 11:00 A.M on Monday, the 30th September, 2024 through Video Conferencing ('VC')/ Other Audio Video Visual Means (OVAM) to seek the approval of members of the Company on resolutions set out in the Notice convening meeting. Read less.. (As Per BSE Announcement Dated on 11.10.2024)

AGM Date: 30 Sep 2025

531633 Pursuant to the Regulation 42 of SEBI (LODR) Regulations, 2015 , we would like to inform you that the 31st Annual General Meeting of the Company is scheduled to be held on Tuesday, September 30, 2025 at 11:00 A.M (IST) through Video Conferencing ('VC')/Other Audio-Visual Means ('OVAM'). 31st Annual General Meeting ('AGM') of the Members of the Company will be held on Tuesday, 30th September, 2025 at 11:00 A.M (IST) through Video Conferencing ('VC')/Other Audio-Visual Means ('OVAM'), in accordance with relevant circulars issued by Ministry of Corporate Affairs and Security and Exchange Board of India. We hereby enclose the Notice of 31st Annual General Meeting of the Company which is being sent to the members through electronic mode. (As Per BSE Announcement Dated on:06.09.2025) Submission of Proceedings of the 31st Annual General Meeting of the Company held today. (As Per BSE Announcement Dated on: 30/09/2025) Submission of E-Voting Results of 31st AGM along with the Scrutinizer Report as per Regulation 44 of SEBI (LODR) Regulation, 2015. Submission of Scrutinizers'' Report of 31st AGM of the Company. (As per BSE Announcement dated on: 03.10.2025) With reference to the above, please find enclosed herewith the Minutes of 31st Annual General Meeting of the Company held at 11:00 A.M on Tuesday, the 30th September, 2025 through Video Conferencing ('VC')/ Other Audio-Video Visual Means (OVAM) to seek the approval of the members of the Company on resolutions set out in the Notice convening meeting. (As per BSE Announcement dated on: 28.10.2025)

Lincoln Pharmaceuticals Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,763.70	₹4,23,170.71
Divis Laboratories Ltd	₹6,523.25	₹1,73,171.79
Torrent Pharmaceuticals Ltd	₹3,816.75	₹1,29,170.36
Cipla Ltd	₹1,536.25	₹1,24,093.85
Dr Reddys Laboratories Ltd	₹1,244.50	₹1,03,868.61

Lincoln Pharmaceuticals Ltd Top Mutal Funds Invested

Fund Name	AUM
Bandhan BSE Healthcare Index Fund	0.04%

Lincoln Pharmaceuticals Ltd News

Lincoln Pharmaceuticals declines after weak Q2 performance

Lincoln Pharmaceuticals slipped 1.05% to Rs 520.65 after the company reported 24.06% fall in consolidated net profit to Rs 20.01 crore on a 0.34% decline in total income to Rs 170.60 crore in Q2 FY26 as compared with Q2 FY25.

13 Nov 2025, 01:59 pm

Lincoln Pharmaceuticals to discuss results

On 13 November 2025

06 Nov 2025, 12:35 pm

Lincoln Pharmaceuticals AGM scheduled

On 30 September 2025

30 Aug 2025, 07:04 pm

Lincoln Pharmaceuticals announces board meeting date

On 7 August 2025

29 Jul 2025, 10:52 am

Board of Lincoln Pharmaceuticals recommends final dividend

Of Rs 1.8 per share

22 May 2025, 06:24 pm

Lincoln Pharmaceuticals Ltd Stock Analysis

Annual revenue for Lincoln Pharmaceuticals Ltd increased by 5.00% to ₹645.71 crore in FY 2025 from ₹614.97 crore in FY 2024.
Annual Net Profit for Lincoln Pharmaceuticals Ltd decreased by 11.74% to ₹82.35 crore in FY 2025 from ₹93.30 crore in FY 2024.
Promoter Shareholding in Lincoln Pharmaceuticals Ltd remains unchanged by 0.00% in the most recent quarter, from 49.78% in June 2025 to 49.78% in September 2025.
Lincoln Pharmaceuticals Ltd delivered a 1-year return of -13.25% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Lincoln Pharmaceuticals Ltd share price moved down by 0.07% from its previous close of INR ₹532.85. The latest Lincoln Pharmaceuticals Ltd share price is INR ₹532.50.
Lincoln Pharmaceuticals Ltd share price today has been at a low of 529.10 and a high of 534.75. Over the past 52 weeks, the Lincoln Pharmaceuticals Ltd share price has seen a low of 490 and a high of 979.50.